Appendix D. Normal Laboratory Values
Manual of Rheumatology and Outpatient Orthopedic Disorders
Stephen A. Paget and Allan Gibofsky
Immunologic
Hematologic
Biochemistry
Endocrine
Quantitative urinary excretion
Table D-1. Normal laboratory values | |
| |
Tests | Normal values |
| |
Immunologic | |
Rheumatoid factor | |
Latex fixation | <1.160 titer |
Rate nephelometric | <30 IU/mL |
Serum complement | |
Total hemolytic complement (CH 50) | 150 “250 Us/mL |
Complement components (immunoassays) | |
C1q | 11 “22 mg/dL |
C2 | 1.6 “3.6 mg/dL |
C3 | 64 “210 md/dL |
C4 | 11.5 “50.0 mg/dL |
C5 | 7.1 “20.4 mg/dL |
C1 esterase inhibitor | 14 “30 mg/dL |
Factor B | 14.8 “31.0 mg/dL |
Antinuclear antibody (ANA) | Negative |
Anti-DNA antibody ( Crithidia immunofluorescence) | Negative |
Anti-streptolysin O (ASO) | 0 “125 Todd units |
Serum immunoglobulins (immunoassay) | |
IgG | 723 “1685 mg/dL |
IgA | 69 “382 mg/dL |
IgM | 63 “277 mg/dL |
Hematologic | ||
Blood counts | Males | Females |
CBC (includes five-part differential) | 3.5 “10.7 | 3.5 “10.7 |
RBC — 10 12 /L | 4.2 “5.6 | 4.0 “5.2 |
HGB (g/dL) | 13 “17 | 11.5 “16.0 |
HCT (%) | 38 “52 | 34 “46 |
MCV (fl) | 82 “98 | 82 “98 |
PLT — 10 9 /L | 160 to 400 | |
Differential | % | Absolute |
Neutrophils | 40.0 “74.0 | 1.90 “8.00 |
Lymphocytes | 19.0 “48.0 | 0.90 “5.20 |
Monocytes | 3.4 “9.0 | 0.16 “1.00 |
Eosinophils | 0.0 “7.0 | 0.00 “0.80 |
Basophils | 0.0 “1.5 | 0.00 “0.20 |
Larger unstained cells | 0.0 “4.0 | |
Stained smears ”bands | 0 “12 mm/h males <10% | |
Sedimentation rate (Westergren) | 0 “27 mm/h females | |
Activated partial thromboplastin time (aPTT) | Upper limit 38.0 sec | |
Prothrombin time (PT) (dependent on reagent lot No.) | Upper limit 13.0 sec | |
Fibrinogen | 200 “400 mg/dL |
Biochemistry | |
Acid phosphatase (spectrophotometry) | 0 “5.5 µ/L |
Albumin (modified Doumas) | 3.5 “5.0 g/dL |
Aldolase (ultraviolet, kinetic) | 0 “7.4 µ/L |
Alkaline phosphatase (Bowers & McComb) | 30 “110 µ/L |
Amylase (enzymatic /kinetic) | 25 “125 µ/L |
Bicarbonate (enzymatic oxidation) | 23 “35 mEq/L |
Bilirubin, total (azobilirubin) | 0 “1.0 mg/dL |
Calcium ( o -cresophthalein complex 1) | 8.5 “10.5 mg/dL |
Chloride (ion-selective electrode) | 97 “107 mEq/L |
Cholesterol (enzymatic) | 150 “240 mg/dL |
Creatine kinase (enzymatic/kinetic) | 40 “175 females 40 “225 µ/L males |
Creatinine (modified Jaffe) | 0.4 “1.2 mg/dL |
GGTP (modified Rosalki & Tarlow) | 0 “70 µ/L |
Glucose (hexokinase) | 70 “105 mg/dL |
Iron (ferrozine) | 20 “170 µg/dL females 20 “200 µg/dL males |
Iron-binding capacity (ferrozine) | 250 “450 µg/dL |
LDH (modified Amador) | 80 “200 µ/L |
5'-NT ( enzyme kinetic) | 4 “11.5 µ/L |
Phosphorus, inorganic (modified Fiske & Subbarow) | 2.5 “5.0 mg/dL |
Potassium (ion-selective electrode) | 3.5 “5.0 mEq/L |
Protein, total (Biuret) | 6.0 “8.0 g/dL |
Salicylate (colorimetric You & Roe) therapeutic level | 6 “20 mg/dL |
SGOT (AST) (modified Scandinavian) | 10 “45 µ/L |
SGPT (ALT) (modified Scandinavian) | 0 “40 µ/L |
Sodium (ion-selective electrode) | 135 “145 mEq/L |
Triglyceride (enzymatic/colorimetric) | 72 “174 mg/dL |
Urea nitrogen (modified Talke & Schubert) | 5 “25 mg/dL |
Uric acid (uricase Trivedi) | 2.0 “9.0 mg/dL |
Endocrine | |
T 4 (immunoassay) | 4.9 “10.7 µg/dL |
T 3 uptake (immunoassay) | 28% “36% |
T 3 RIA (immunoassay) | |
0 to 14 y | 125 “250 ng/dL |
14 to 23 y | 100 “220 ng/dL |
> 24y | 80 “180 ng/dL |
Intact PTH (immunochemiluminescent assay) | 1.0 “5.0 pmol/L |
N-terminal PTH (immunochemiluminescent assay) | 0 “6.1 pmol/L |
C-terminal PTH (radioimmunoassay) | 0 “50 mEq/mL |
Quantitative urinary excretion | |
Calcium | 50 “400 mg/24 h |
Hydroxyproline, total | 15 “45 mg/24 h |
Magnesium | 75 “150 mg/24 h |
Sodium | 43 “217 mg/24 h |
Potassium | 26 “123 mEq/24 h |
Phosphorus (inorganic) | 340 “1,100 mg/24 h |
Amylase (enzymatic/kinetic) | 1 “17 U/h |
Protein | 10 “100 mg/24 h |
Creatinine | 800 “1,900 mg/24 h |
Creatinine clearance | 70 “180 mL/min |
Uric acid (diet-dependent) | 250 “750 mg/24 h |
|
Books@Ovid
Copyright 2000 by Lippincott Williams & Wilkins
Stephen A. Paget, M.D., Allan Gibofsky, M.D., J.D. and John F. Beary, III, M.D.
Manual of Rheumatology and Outpatient Orthopedic Disorders